Literature DB >> 6875545

Tetanus and botulinum toxins inhibit, and black widow spider venom stimulates the release of methionine-enkephalin-like material in vitro.

P K Janicki, E Habermann.   

Abstract

The actions of tetanus toxin, botulinum A toxin, and black widow spider venom on the release of methionine-enkephalin-like immunoreactivity have been studied; a particulate fraction prepared from rat striata was used. Depending on the duration of preincubation, tetanus toxin diminished the release evoked by veratridine (50 microM final concentration), and abolished it at final concentrations between 0.1 and 1 micrograms/ml. Botulinum A toxin was about 10 to 20 times less potent. Heating or pretreatment with antitoxin inactivated the clostridial toxins. The particulate fraction pretreated with V. cholerae neuraminidase retained its toxin sensitivity. Tetanus toxin also depressed the release due to sea anemone toxin II and high K+. Spider venom stimulated the release in a concentration-dependent manner and required the presence of Ca2+; its effects were depressed by tetanus toxin. These results support the view that both clostridial toxins and spider venom act as broad-range presynaptic neurotoxins on peptidergic transmitter systems.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6875545     DOI: 10.1111/j.1471-4159.1983.tb04755.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

1.  Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.

Authors:  B Poulain; L Tauc; E A Maisey; J D Wadsworth; P M Mohan; J O Dolly
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

2.  Selective effects of neuronal-synaptobrevin mutations on transmitter release evoked by sustained versus transient Ca2+ increases and by cAMP.

Authors:  M Yoshihara; A Ueda; D Zhang; D L Deitcher; T L Schwarz; Y Kidokoro
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

3.  [Long-term treatment of phantom- and stump pain with Botulinum toxin type A over 12 months. A first clinical observation].

Authors:  U Kern; C Martin; S Scheicher; H Müller
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 4.  Penelope's web: using alpha-latrotoxin to untangle the mysteries of exocytosis.

Authors:  John-Paul Silva; Jason Suckling; Yuri Ushkaryov
Journal:  J Neurochem       Date:  2009-08-13       Impact factor: 5.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.